Healthcare provider profile · identity verified

Matthew R. Giese, MD

Family Practice · ORANGE, VA · NPI 1417011925

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	729	186
Losartan Potassium	Losartan Potassium	375	95
Lisinopril	Lisinopril	366	88
Amlodipine Besylate	Amlodipine Besylate	324	86
Omeprazole	Omeprazole	320	72
Metformin Hcl	Metformin Hcl	246	59
Levothyroxine Sodium	Levothyroxine Sodium	242	54
Hydrochlorothiazide	Hydrochlorothiazide	213	59
Simvastatin	Simvastatin	192	48
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	167	41
Metoprolol Succinate	Metoprolol Succinate	160	40
Albuterol Sulfate Hfa	Albuterol Sulfate	156	57
Montelukast Sodium	Montelukast Sodium	150	39
Tamsulosin Hcl	Tamsulosin Hcl	141	44
Gabapentin	Gabapentin	119	28
Escitalopram Oxalate	Escitalopram Oxalate	118	25
Metoprolol Tartrate	Metoprolol Tartrate	117	26
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	116	25
Prednisone	Prednisone	116	91
Eliquis	Apixaban	115	18
Sertraline Hcl	Sertraline Hcl	110	23
Furosemide	Furosemide	100	24
Trazodone Hcl	Trazodone Hcl	97	24
Pravastatin Sodium	Pravastatin Sodium	94	20
Pantoprazole Sodium	Pantoprazole Sodium	89	22
Allopurinol	Allopurinol	87	23
Duloxetine Hcl	Duloxetine Hcl	84	19
Metformin Hcl Er	Metformin Hcl	79	20
Rosuvastatin Calcium	Rosuvastatin Calcium	76	19
Carvedilol	Carvedilol	64	18
Fluticasone Propionate	Fluticasone Propionate	64	22
Ozempic	Semaglutide	64	14
Bupropion Xl	Bupropion Hcl	59	13
Meloxicam	Meloxicam	59	15
Tramadol Hcl	Tramadol Hcl	59	14
Glipizide	Glipizide	53	13
Venlafaxine Hcl Er	Venlafaxine Hcl	53	11
Azithromycin	Azithromycin	52	46
Famotidine	Famotidine	50	13
Glipizide Er	Glipizide	50	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	50	suppressed
Pregabalin	Pregabalin	49	suppressed
Chlorthalidone	Chlorthalidone	47	13
Clopidogrel	Clopidogrel Bisulfate	47	11
Citalopram Hbr	Citalopram Hydrobromide	44	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	44	suppressed
Alendronate Sodium	Alendronate Sodium	42	16
Rybelsus	Semaglutide	42	suppressed
Ibuprofen	Ibuprofen	39	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	38	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	36	34
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	35	27
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	34	31
Amoxicillin	Amoxicillin	33	31
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	33	15
Fluoxetine Hcl	Fluoxetine Hcl	33	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	33	28
Naproxen	Naproxen	32	32
Ropinirole Hcl	Ropinirole Hcl	31	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	31	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	29	suppressed
Atenolol	Atenolol	29	suppressed
Breo Ellipta	Fluticasone/Vilanterol	29	suppressed
Lorazepam	Lorazepam	29	suppressed
Spironolactone	Spironolactone	28	suppressed
Synthroid	Levothyroxine Sodium	28	suppressed
Xarelto	Rivaroxaban	28	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	27	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	23	suppressed
Symbicort	Budesonide/Formoterol Fumarate	23	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	22	21
Warfarin Sodium	Warfarin Sodium	21	suppressed
Colchicine	Colchicine	20	suppressed
Donepezil Hcl	Donepezil Hcl	20	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	20	20
Spiriva Respimat	Tiotropium Bromide	20	suppressed
Ventolin Hfa	Albuterol Sulfate	20	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	19	suppressed
Baclofen	Baclofen	19	12
Diclofenac Sodium	Diclofenac Sodium	19	suppressed
Fluconazole	Fluconazole	19	15
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Propranolol Hcl Er	Propranolol Hcl	19	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	19	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Glimepiride	Glimepiride	18	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	18	suppressed
Cephalexin	Cephalexin	17	16
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Estradiol	Estradiol	16	suppressed
Finasteride	Finasteride	16	suppressed
Mirtazapine	Mirtazapine	16	suppressed
Celecoxib	Celecoxib	15	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	15	suppressed
Valsartan	Valsartan	15	suppressed
Cefuroxime	Cefuroxime Axetil	14	13
Ciclopirox	Ciclopirox Olamine	14	suppressed
Ibu	Ibuprofen	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Nebivolol Hcl	Nebivolol Hcl	14	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	11
Januvia	Sitagliptin Phosphate	13	suppressed
Jardiance	Empagliflozin	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	11
Metoclopramide Hcl	Metoclopramide Hcl	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	13	suppressed
Topiramate	Topiramate	13	suppressed
Bumetanide	Bumetanide	12	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Descovy	Emtricitabine/Tenofov Alafenam	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Glatiramer Acetate	Glatiramer Acetate	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Tivicay	Dolutegravir Sodium	12	suppressed
Tizanidine Hcl	Tizanidine Hcl	12	suppressed
Trimethoprim	Trimethoprim	12	suppressed
Cilostazol	Cilostazol	11	suppressed
Nystatin	Nystatin	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error